软组织-话题@MedSci

#软组织#

142篇内容 | 3449人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2204296, encodeId=67a82204296f4, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a> <a href='/topic/show?id=9146e5912d1' target=_blank style='color:#2F92EE;'>#筋膜#</a>, objectTitle=筋膜的健康离不开运动，肌痛的治疗不可忽视筋膜, objectType=article, longId=825509, objectId=1e9a82550938, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240512/1715511670471_5579292.jpg, objectUrl=/article/show_article.do?id=1e9a82550938, replyNumber=0, likeNumber=84, createdTime=2024-05-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1e9a82550938, moduleTitle=筋膜的健康离不开运动，肌痛的治疗不可忽视筋膜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e9a82550938)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1420484, encodeId=10cf14204848e, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=百奥赛图与TRACON共同宣布YH001（CTLA-4单抗）联合恩沃利单抗（PD-L1）一线治疗软组织肉瘤的临床试验申请获得FDA批准, objectType=article, longId=737420, objectId=555de3742013, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=555de3742013, replyNumber=0, likeNumber=71, createdTime=2022-09-01, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=555de3742013, moduleTitle=百奥赛图与TRACON共同宣布YH001（CTLA-4单抗）联合恩沃利单抗（PD-L1）一线治疗软组织肉瘤的临床试验申请获得FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=555de3742013)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420483, encodeId=60261420483f0, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗晚期软组织肉瘤的效果可期！, objectType=article, longId=731131, objectId=289fe31131ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=289fe31131ee, replyNumber=0, likeNumber=99, createdTime=2022-07-04, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=289fe31131ee, moduleTitle=Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗晚期软组织肉瘤的效果可期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=289fe31131ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420481, encodeId=ab0b1420481f0, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=European Radiology:用这个MRI序列，对软组织肉瘤进行病理级放大！, objectType=article, longId=731050, objectId=eac8e3105041, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eac8e3105041, replyNumber=0, likeNumber=76, createdTime=2022-07-03, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eac8e3105041, moduleTitle=European Radiology:用这个MRI序列，对软组织肉瘤进行病理级放大！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eac8e3105041)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420482, encodeId=52591420482e7, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=J Antimicrob Chemother：口服康泰克唑烷治疗成人复杂皮肤和软组织感染的效果不劣于与利奈唑胺, objectType=article, longId=730960, objectId=e9b0e30960ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9b0e30960ac, replyNumber=0, likeNumber=83, createdTime=2022-07-02, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9b0e30960ac, moduleTitle=J Antimicrob Chemother：口服康泰克唑烷治疗成人复杂皮肤和软组织感染的效果不劣于与利奈唑胺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9b0e30960ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420480, encodeId=d0041420480ea, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗局部晚期/转移性软组织肉瘤, objectType=article, longId=729559, objectId=1586e2955944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1586e2955944, replyNumber=0, likeNumber=87, createdTime=2022-06-16, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1586e2955944, moduleTitle=Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗局部晚期/转移性软组织肉瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1586e2955944)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420479, encodeId=230314204e9e7, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Clin Cancer Res：采用卡博替尼单药治疗晚期软组织肉瘤, objectType=article, longId=294798, objectId=9a57294e98ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a57294e98ea, replyNumber=0, likeNumber=96, createdTime=2022-01-28, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a57294e98ea, moduleTitle=Clin Cancer Res：采用卡博替尼单药治疗晚期软组织肉瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a57294e98ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420477, encodeId=203914204e73b, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=BMC Cancer：白蛋白紫杉醇联合PD-1抑制剂信迪利单抗是晚期软组织肉瘤(STS)的有前景治疗方案, objectType=article, longId=294052, objectId=a3fb294052fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3fb294052fd, replyNumber=0, likeNumber=81, createdTime=2022-01-17, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3fb294052fd, moduleTitle=BMC Cancer：白蛋白紫杉醇联合PD-1抑制剂信迪利单抗是晚期软组织肉瘤(STS)的有前景治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3fb294052fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420476, encodeId=478214204e67c, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle= 你所不了解的流变特性，正在悄然影响着软组织填充剂 , objectType=article, longId=293488, objectId=e66529348875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e66529348875, replyNumber=0, likeNumber=88, createdTime=2022-01-07, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e66529348875, moduleTitle= 你所不了解的流变特性，正在悄然影响着软组织填充剂 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e66529348875)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420478, encodeId=7e1114204e868, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=European Radiology：深度学习+放射组学！让软组织肉瘤复发无处遁形！, objectType=article, longId=292483, objectId=ca262924837c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca262924837c, replyNumber=0, likeNumber=87, createdTime=2021-12-23, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca262924837c, moduleTitle=European Radiology：深度学习+放射组学！让软组织肉瘤复发无处遁形！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca262924837c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420475, encodeId=f04314204e548, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Clin Cancer Res：Cabozantinib（卡博替尼）单药治疗难治性软组织肉瘤(STS)的疗效和安全性, objectType=article, longId=291974, objectId=52c52919e488, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52c52919e488, replyNumber=0, likeNumber=113, createdTime=2021-12-18, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52c52919e488, moduleTitle=Clin Cancer Res：Cabozantinib（卡博替尼）单药治疗难治性软组织肉瘤(STS)的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52c52919e488)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420474, encodeId=5a0e14204e4e1, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Clin Cancer Res：多受体酪氨酸激酶抑制剂卡博替尼单药治疗晚期软组织肉瘤的效果, objectType=article, longId=220644, objectId=1bac22064495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bac22064495, replyNumber=0, likeNumber=79, createdTime=2021-11-21, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bac22064495, moduleTitle=Clin Cancer Res：多受体酪氨酸激酶抑制剂卡博替尼单药治疗晚期软组织肉瘤的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bac22064495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420485, encodeId=e83c14204851f, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=骨与软组织肿瘤NGS中国专家共识（2021年版）, objectType=article, longId=291635, objectId=7277291635f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7277291635f4, replyNumber=0, likeNumber=90, createdTime=2021-11-10, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7277291635f4, moduleTitle=骨与软组织肿瘤NGS中国专家共识（2021年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7277291635f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420473, encodeId=82bb14204e34e, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=你所不了解的流变特性，正在悄然影响着软组织填充剂, objectType=article, longId=218341, objectId=ea8a218341a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea8a218341a7, replyNumber=0, likeNumber=77, createdTime=2021-10-11, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea8a218341a7, moduleTitle=你所不了解的流变特性，正在悄然影响着软组织填充剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea8a218341a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420472, encodeId=ef4714204e289, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Ann Oncol：曲贝替定（trabectedin）对比更佳支持治疗在既往治疗过的软组织肉瘤患者的疗效和评估：III期随机研究T-SAR, objectType=article, longId=214527, objectId=843721452e12, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=843721452e12, replyNumber=0, likeNumber=68, createdTime=2021-07-22, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=843721452e12, moduleTitle=Ann Oncol：曲贝替定（trabectedin）对比更佳支持治疗在既往治疗过的软组织肉瘤患者的疗效和评估：III期随机研究T-SAR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=843721452e12)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420471, encodeId=910714204e1a2, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Br J Cancer：调节性T细胞可预测软组织肉瘤患者的临床结果, objectType=article, longId=212781, objectId=c401212e8141, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c401212e8141, replyNumber=0, likeNumber=72, createdTime=2021-06-17, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c401212e8141, moduleTitle=Br J Cancer：调节性T细胞可预测软组织肉瘤患者的临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c401212e8141)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420470, encodeId=f77214204e07d, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Br J Cancer：帕唑帕尼与拓扑替康联合治疗转移性和不可切除性软组织肉瘤患者的II期临床研究, objectType=article, longId=212072, objectId=e36e2120e2eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e36e2120e2eb, replyNumber=0, likeNumber=78, createdTime=2021-06-01, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e36e2120e2eb, moduleTitle=Br J Cancer：帕唑帕尼与拓扑替康联合治疗转移性和不可切除性软组织肉瘤患者的II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e36e2120e2eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420469, encodeId=78f7142046972, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Clin Cancer Res：3期试验| 阿霉素治疗对晚期软组织肉瘤患者的心脏毒性, objectType=article, longId=207726, objectId=b5f320e726da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5f320e726da, replyNumber=0, likeNumber=92, createdTime=2021-03-01, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5f320e726da, moduleTitle=Clin Cancer Res：3期试验| 阿霉素治疗对晚期软组织肉瘤患者的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5f320e726da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420468, encodeId=96c8142046888, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Eur Radiol：软组织肉瘤患者要警惕胸部转移的存在！, objectType=article, longId=207537, objectId=70f820e53739, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70f820e53739, replyNumber=0, likeNumber=86, createdTime=2021-02-25, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70f820e53739, moduleTitle=Eur Radiol：软组织肉瘤患者要警惕胸部转移的存在！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70f820e53739)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420467, encodeId=e1c4142046e43, content=<a href='/topic/show?id=2221935219e' target=_blank style='color:#2F92EE;'>#软组织#</a>, objectTitle=Annamycin治疗软组织肉瘤，已获得FDA“孤儿药称号”, objectType=article, longId=205042, objectId=b142205042e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b142205042e2, replyNumber=0, likeNumber=74, createdTime=2021-01-01, rootId=0, userName=qilu_qi, userId=52913579937, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b142205042e2, moduleTitle=Annamycin治疗软组织肉瘤，已获得FDA“孤儿药称号”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b142205042e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

软组织

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#软组织# #筋膜#

筋膜的健康离不开运动，肌痛的治疗不可忽视筋膜

2024-05-12发表于上海

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

百奥赛图与TRACON共同宣布YH001（CTLA-4单抗）联合恩沃利单抗（PD-L1）一线治疗软组织肉瘤的临床试验申请获得FDA批准

2022-09-01

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗晚期软组织肉瘤的效果可期！

2022-07-04

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

European Radiology:用这个MRI序列，对软组织肉瘤进行病理级放大！

2022-07-03

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

J Antimicrob Chemother：口服康泰克唑烷治疗成人复杂皮肤和软组织感染的效果不劣于与利奈唑胺

2022-07-02

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Clin Cancer Res：新型PD-L1抗体TQB2450联合安罗替尼治疗局部晚期/转移性软组织肉瘤

2022-06-16

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Clin Cancer Res：采用卡博替尼单药治疗晚期软组织肉瘤

2022-01-28

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

BMC Cancer：白蛋白紫杉醇联合PD-1抑制剂信迪利单抗是晚期软组织肉瘤(STS)的有前景治疗方案

2022-01-17

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

你所不了解的流变特性，正在悄然影响着软组织填充剂

2022-01-07

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

European Radiology：深度学习+放射组学！让软组织肉瘤复发无处遁形！

2021-12-23

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Clin Cancer Res：Cabozantinib（卡博替尼）单药治疗难治性软组织肉瘤(STS)的疗效和安全性

2021-12-18

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Clin Cancer Res：多受体酪氨酸激酶抑制剂卡博替尼单药治疗晚期软组织肉瘤的效果

2021-11-21

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

骨与软组织肿瘤NGS中国专家共识（2021年版）

2021-11-10

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

你所不了解的流变特性，正在悄然影响着软组织填充剂

2021-10-11

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Ann Oncol：曲贝替定（trabectedin）对比更佳支持治疗在既往治疗过的软组织肉瘤患者的疗效和评估：III期随机研究T-SAR

2021-07-22

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Br J Cancer：调节性T细胞可预测软组织肉瘤患者的临床结果

2021-06-17

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Br J Cancer：帕唑帕尼与拓扑替康联合治疗转移性和不可切除性软组织肉瘤患者的II期临床研究

2021-06-01

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Clin Cancer Res：3期试验| 阿霉素治疗对晚期软组织肉瘤患者的心脏毒性

2021-03-01

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Eur Radiol：软组织肉瘤患者要警惕胸部转移的存在！

2021-02-25

qilu_qi (审核中...)

前往app查看评论内容

#软组织#

Annamycin治疗软组织肉瘤，已获得FDA“孤儿药称号”

2021-01-01

科室
- - 订阅+
  - 更多科室
工具
服务